Comments

Sarepta Therapeutics

Q: What sector and industry does Sarepta Therapeutics (SRPT) operate in?

Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SRPTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$127.21

0.110.09%

At Close: -

$127.21

00.00%

After Hours: 4:03 PM EDT

15 minutes delayed

Sarepta Therapeutics (SRPT) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

100

0100

Financials Analysis

0100

Sarepta Therapeutics (NASDAQ:SRPT) Stock Quotes, Forecast and News Summary

Sarepta Therapeutics Stock (NASDAQ: SRPT) stock price, news, charts, stock research, profile.

Open	$127.10
Close	$127.21
Volume / Avg.	997.66K / 1.42M
Day Range	$125.05 - $129.01
52 Wk Range	55.25 - 173.25
Market Cap	$12.13B
P/E Ratio	169.47
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	7.16%
Days to Cover	9.23

Recent News

Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy

Dyne Therapeutics revealed new clinical data from its Phase 1/2 DELIVER trial of DYNE-251 for Duchenne muscular dystrophy, showing significant increases in dystrophin expression and meaningful functional improvements.

Vandana Singh

Warner Bros, Airbnb And Monster Beverage Are Among Top 10 Large Cap Losers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?

These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. being the worst performers.

Lekha Gupta

McKesson Reports Weak Sales, Joins JFrog, Fastly, Warner Bros. Discovery And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Sarepta Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Sarepta Therapeutics (SRPT) stock?

You can purchase shares of Sarepta Therapeutics (NASDAQ:SRPT) through any online brokerage.

View our list of the best stock brokerages

Who are Sarepta Therapeutics (SRPT) competitors?

Other companies in Sarepta Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Sarepta Therapeutics (SRPT) stock?

Sarepta Therapeutics has a consensus price target of $185.86.

What is the current price for Sarepta Therapeutics (SRPT)?

The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $127.21 last updated September 20, 2024 at 4:03 PM EDT.

Does Sarepta Therapeutics (SRPT) pay a dividend?

There are no upcoming dividends for Sarepta Therapeutics.

When is Sarepta Therapeutics (NASDAQ:SRPT) reporting earnings?

Sarepta Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.

Is Sarepta Therapeutics (SRPT) going to split?

There is no upcoming split for Sarepta Therapeutics.

What sector and industry does Sarepta Therapeutics (SRPT) operate in?

Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now